Physician
Obstetrics & Gynecology
Dr. John H. Farley, MD
|
|
Give Review
John Farley is an expert in the field of Obstetrics & Gynecology. He attended Uniformed Services University of the Health Sciences. Uniformed Services University of the Health Sciences has a rank of 72 in research and a 47 in primary care He received awards:"Fellow (FACS)". John H. Farley, MD is a published doctor as well. He has 51 publications published. The latest was: Ureteral carcinoma presenting as a complex pelvic mass in a post menopausal patient. He is registered with Medicare.
Publications
- Gynecologic cancer disparities: A report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.
- Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.
- MEK1/2 inhibitors in the treatment of gynecologic malignancies.
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study.
- Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment.
- The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: A gynecologic oncology group s...
- Deciphering surveillance, epidemiology, and end results data analysis : Are We Seeing the Whole Picture?
- Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study.
- Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials.
- Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer.
- Adaptation and quality of life among long-term cervical cancer survivors in the military health care system.
- Complications of gynecologic surgery.
- Patterns of care for cervical cancer patients treated in the U.S. military health care system.
- A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia.
- Far forward gynecologic care of the female soldier.
- Treatment of metastatic gestational choriocarcinoma with oral methotrexate in a combat environment.
- Biologic directed therapies in gynecologic oncology.
- Asian-Pacific Islander race independently predicts poor outcome in patients with endometrial cancer.
- Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
- Ethnic differences in survival among Pacific Island patients diagnosed with cervical cancer.
- Adenocarcinoma of unknown primary site presenting as an isolated retroperitoneal mass and Trousseau's syndrome.
- Cell cycle and related protein.
- Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C.
- Chest wall tumors: experience with 58 patients.
- Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian...
- Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: A gynecologic oncology group study.
- Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immu...
- Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure.
- Racial disparities in blacks with gynecologic cancers.
- Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gyne...
- The role of p27 in endometrial carcinoma.
- Equal care ensures equal survival for African-American women with cervical carcinoma.
- Recurrent squamous cell carcinoma of the Bartholin's duct treated with en bloc resection.
- Risk factors for early cytologic abnormalities after loop electrosurgical excision procedure.
- Grading of squamous dysplasia in endocervical curettage specimens: The case for conservative management of mild endocervical dysplasia.
- Age-specific survival of women with endometrioid adenocarcinoma of the uterus.
- Cervical carcinosarcoma occurring after subtotal hysterectomy, a case report.
- Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.
- Trial design for evaluation of novel targeted therapies.
- Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial.
- Long-term impact of the women''s health initiative on HRT.
- Ureteral carcinoma presenting as a complex pelvic mass in a post menopausal patient.
- Late presentation of an alpha-fetoprotein secreting isolated large upper abdominal retroperitoneal Sertoli-Leydig cell tumor recurrence.
- Collision of uterine rhabdoid tumor and endometrioid adenocarcinoma: a case report and review of the literature.
- Biomarkers and clinical trial design.
- The future of phase II trials.
- Current techniques for the evaluation of abnormal cervical cytology.
- Novel therapeutic targets.
- Genomic analysis of epithelial ovarian cancer.
- Ovarian cancer: markers of response.
Schools
Uniformed Services University of Health Sciences
Walter Reed Army Medical Center
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Uniformed Services University of the Health Sciences
Hospital
-
St. Joseph's Hospital and Medical Center -
Chandler Regional Medical Center
Drug Facts
| NPI NUMBER | 1427034578 | |
| NPPES Provider LastName | FARLEY | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 850134224 | |
| NPPES Provider State | AZ | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 13.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427034578 |
| Last Name Of The Provider | FARLEY |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
Dr. Shana N. Wingo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew P. Borst, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Dana M. Chase, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bradley J. Monk, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Paul M. Magtibay, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sharon R. Thompson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vicente O. Enciso Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nichelle E. Whitehead, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria Manriquez, MD |
|
|
Dr. Michael Wilson, MD |
|
|
Dr. Vanna L. Zanagnolo, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Cara M. Christ, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diana M. Herman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan N. Gordon, MD
This Doctor is OpenDoctor Recommended.
|